INTERNATIONAL PATENT: MIBIOME THERAPEUTICS LLP FILES APPLICATION FOR "COMPOSITION AND METHOD FOR DETECTION OF MULTIPLE DRUG RESISTANCE IN TUBERCULOSIS BY MULTIPLEX SHORT-AMPLICON BASED TARGETED NGS (TNGS) USING RIBONUCLEOTIDE BASES IN THE PRIMERS TO INCREASE TARGET SPECIFICITY"

GENEVA, April 13 -- MIBIOME THERAPEUTICS LLP (Flexcel Park, C Wing, S. V. Road, Jogeshwari West, Mumbai 400102, Maharashtra, IndiaMumbai 400102) filed a patent application (PCT/IN2025/051577) for "COMPOSITION AND METHOD FOR DETECTION OF MULTIPLE DRUG RESISTANCE IN TUBERCULOSIS BY MULTIPLEX SHORT-AMPLICON BASED TARGETED NGS (TNGS) USING RIBONUCLEOTIDE BASES IN THE PRIMERS TO INCREASE TARGET SPECIFICITY" on Sep 27, 2025. With publication no. WO/2026/074580, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DAS, Gautam (Flexce...